Page last updated: 2024-08-26

u 69593 and 4-[[(4-methylphenyl)sulfonylamino]methyl]-N-[2-[(phenylmethyl)-propan-2-ylamino]ethyl]benzamide

u 69593 has been researched along with 4-[[(4-methylphenyl)sulfonylamino]methyl]-N-[2-[(phenylmethyl)-propan-2-ylamino]ethyl]benzamide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aubé, J; Bohn, LM; Frankowski, KJ; Lovell, KM; Phillips, AM; Prisinzano, TE; Schoenen, FJ; Slauson, SR; Streicher, JM; Whipple, DA; Zhou, L	1

Other Studies

1 other study(ies) available for u 69593 and 4-[[(4-methylphenyl)sulfonylamino]methyl]-N-[2-[(phenylmethyl)-propan-2-ylamino]ethyl]benzamide

Article	Year
Potency enhancement of the κ-opioid receptor antagonist probe ML140 through sulfonamide constraint utilizing a tetrahydroisoquinoline motif. Bioorganic & medicinal chemistry, 2015, Jul-15, Volume: 23, Issue:14 Topics: Animals; Arrestins; Benzamides; beta-Arrestins; Chemistry Techniques, Synthetic; CHO Cells; Cricetulus; Drug Evaluation, Preclinical; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Naltrexone; Narcotic Antagonists; Receptors, Opioid, kappa; Structure-Activity Relationship; Sulfonamides; Tetrahydroisoquinolines	2015

Article

Year

Potency enhancement of the κ-opioid receptor antagonist probe ML140 through sulfonamide constraint utilizing a tetrahydroisoquinoline motif.

Bioorganic & medicinal chemistry, 2015, Jul-15, Volume: 23, Issue:14

Topics: Animals; Arrestins; Benzamides; beta-Arrestins; Chemistry Techniques, Synthetic; CHO Cells; Cricetulus; Drug Evaluation, Preclinical; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Naltrexone; Narcotic Antagonists; Receptors, Opioid, kappa; Structure-Activity Relationship; Sulfonamides; Tetrahydroisoquinolines

2015